Biogen

Company BIIB

Last mentioned: Mar 23, 2026

Timeline

  1. Official Rollout

    Scotland officially begins screening all newborns for the rare muscle disease.

  2. Data Evaluation

    Expected first review of screening efficacy and treatment referral rates in Scotland.

  3. Scottish Policy Review

    Scottish health officials evaluate the feasibility of independent implementation.

  4. Clinical Advocacy

    Intense campaigning by rare disease groups for the inclusion of SMA in UK-wide screening.

Stories mentioning Biogen 1